Investigations	
Platelet count decreased	8 (3.4)
Neutrophil count decreased	3 (1.3)
Alanine aminotransferase increased	10 (4.3)
Aspartate aminotransferase increased	12 (5.2)
White blood cell count decreased	2 (0.9)
Gamma-glutamyltransferase increased	7 (3.0)
Blood bilirubin increased	3 (1.3)
Bilirubin conjugated increased	3 (1.3)
Blood creatinine increased	1 (0.4)
Blood thyroid stimulating hormone increased	1 (0.4)
Blood alkaline phosphatase increased	0
Blood bilirubin unconjugated increased	1 (0.4)
Blood pressure increased	0
Lymphocyte count decreased	0
Plateletcrit decreased	0
Protein urine present	0
Thyroxine free decreased	1 (0.4)
Tri-iodothyronine decreased	1 (0.4)
Tri-iodothyronine free decreased	1 (0.4)
Vascular disorders	
Hypertension	2 (0.9)
Embolism	0
Haematoma	0
Skin and subcutaneous tissue disorders	
Palmar-plantar erythrodysaesthesia syndrome	0
Rash	2 (0.9)
Drug eruption	1 (0.4)
Dermatitis acneiform	1 (0.4)
Dermatitis bullous	1 (0.4)
Immune-mediated dermatitis	1 (0.4)
Gastrointestinal disorders	
Diarrhoea	3 (1.3)
Haematochezia	1 (0.4)
Abdominal pain	3 (1.3)
Vomiting	1 (0.4)
Lower gastrointestinal haemorrhage	0
Mouth ulceration	1 (0.4)
Abdominal distension	0
Enteritis	1 (0.4)
Flatulence	0
Gingival bleeding	1 (0.4)
Intestinal obstruction	0
Large intestine perforation	1 (0.4)
Nausea	1 (0.4)
Rectal haemorrhage	0
Rectal ulcer	0
Stomatitis	0
Renal and urinary disorders	
Proteinuria	3 (1.3)
Haematuria	1 (0.4)
Renal impairment	1 (0.4)
Metabolism and nutrition disorders	
Decreased appetite	2 (0.9)
Hypertriglyceridaemia	0
Hyperlipidaemia	1 (0.4)
Hyperglycaemia	1 (0.4)
Hyperkalaemia	1 (0.4)
Hypomagnesaemia	0
Blood and lymphatic system disorders	
Anaemia	1 (0.4)
Myelosuppression	1 (0.4)
Endocrine disorders	
Hypothyroidism	2 (0.9)
Thyroiditis	2 (0.9)
Autoimmune thyroiditis	1 (0.4)
Hyperthyroidism	1 (0.4)
General disorders and administration site conditions	
Asthenia	2 (0.9)
Pyrexia	2 (0.9)
Oedema peripheral	1 (0.4)
Respiratory, thoracic and mediastinal disorders	
Pneumonitis	2 (0.9)
Epistaxis	0
Bronchial haemorrhage	1 (0.4)
Infections and infestations	
Urinary tract infection	0
Conjunctivitis	1 (0.4)
Cystitis	0
Gingivitis	1 (0.4)
Pelvic inflammatory disease	1 (0.4)
Pneumonia bacterial	1 (0.4)
Staphylococcal infection	1 (0.4)
Cardiac disorders	
Bradycardia	0
Cardiac failure	1 (0.4)
Myocardial ischaemia	1 (0.4)
Sinus tachycardia	1 (0.4)
Hepatobiliary disorders	
Hepatic function abnormal	2 (0.9)
Immune-mediated hepatitis	1 (0.4)
Jaundice	1 (0.4)
Neoplasms benign, malignant and unspecified (incl cysts and polyps)	
Tumour haemorrhage	0
Tumour exudation	0
Nervous system disorders	
Cognitive disorder	1 (0.4)
Headache	1 (0.4)
Reproductive system and breast disorders	
Vaginal haemorrhage	0
Female genital tract fistula	1 (0.4)
Immune system disorders	
Reactive capillary endothelial proliferation	0
Musculoskeletal and connective tissue disorders	
Bone pain	0
